The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.
Hosted on MSN2mon
'I Was Diagnosed With a Rare Genetic Condition At 20—These Are the First Symptoms I Noticed'Sean Korbitz was a 20-year-old college student when he first started experiencing symptoms of von Hippel-Lindau syndrome ... Update After Fighting a Rare Disease Korbitz’s emergency brain ...
as a single agent for the treatment of adults with von Hippel-Lindau (VHL) disease and advanced clear cell renal cell carcinoma (RCC). Welireg is intended for adults with VHL disease who need ...
Motzer and colleagues present updated results from a multicenter, phase III trial of sunitinib versus interferon-α as first-line treatment ... mutations of the von Hippel–Lindau gene.
The Canadian Press on MSN14d
Nova Scotia NDP questions lack of pharmacare deal with OttawaNDP Leader Claudia Chender says pharmacare was left off Nova Scotia’s list of priorities contained in a letter sent earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results